DFDA

Azithromycin

Treatment for Invasive Non Typhoidal Salmonella Ints

Typical Dosage: 500mg orally daily for 7-14 days

Effectiveness
80%
Safety Score
70%
Clinical Trials
150
Participants
15K

Comparative Safety Scale(Higher is safer)

Cyanide☠ī¸
Meth💀
CigarettesđŸšŦ
Chemoâ˜ĸī¸
AlcoholđŸē
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
500mg orally daily for 7-14 days
Time to Effect
3-5 days
Treatment Duration
7-14 days
Evidence Quality
MODERATE
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$40
Monitoring:$500
Side Effect Mgmt:$50
Total Annual:$590
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.18
Outcome-Based Costs
Cost per Responder
$738
Cost per Remission
$738
Prescription Access Economics
Physician Visit Cost
$150/year
Time Cost
$50/year
Travel + wait time
Insurance Admin Cost
$20/year
Prior auth, claims
Rx Price
$40/year
Risk Assessment
Misuse Risk
MODERATE
Missed Diagnosis Risk
HIGH
Requires Monitoring
Yes
Needs lab work/checkups
Azithromycin Outcomes

for Invasive Non Typhoidal Salmonella Ints

Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+80%
Remission Rate
+80%
Common Side Effects
Diarrhea
+7%
Nausea
+5%
Abdominal pain
+3%
QT prolongation
+0.1%

Sources:

ovid.com
nih.gov
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov